CEO Jean Jacques Bienaime sold $2.1M of BioMarin Pharmaceutical Inc.

Sold$2,107,800

$91.64Price

23,000Shares

−3%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Fri, Mar 10. Filed Tue, Mar 14, 7:40 PM ET, after the close. Not investment advice.